Intestinal Epithelial Serum Amyloid A Modulates Bacterial Growth In Vitro and Pro-Inflammatory Responses in Mouse Experimental Colitis

BMC Gastroenterology

Volumn 10, Issue , 2010, Pages

  Eckhardt, Erik R M ^a,b   Witta, Jassir ^b   Zhong, Jian ^b   Arsenescu, Razvan ^b   Arsenescu, Violeta ^a,b   Wang, Yu ^a   Ghoshal, Sarbani ^b   de Beer, Marcielle C ^b   de Beer, Frederick C ^b   de Villiers, Willem J S ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; DEXTRAN SULFATE; DRINKING WATER; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MESSENGER RNA; OSTEOPONTIN; SERUM AMYLOID A; SERUM AMYLOID A1; SERUM AMYLOID A2; SERUM AMYLOID A3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; COCULTURE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; FECES ANALYSIS; GENE EXPRESSION; GENE OVEREXPRESSION; GERMFREE ANIMAL; HEMATOCRIT; HUMAN; HUMAN TISSUE; ILEUM; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE BIOPSY; INTESTINE EPITHELIUM; INTESTINE EPITHELIUM CELL; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BACTERIUM; BIOPSY; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; COMPARATIVE STUDY; DISEASE COURSE; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOBLOTTING; INTESTINE MUCOSA; METABOLISM; MICROBIOLOGY; PATHOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; BACTERIA; BIOPSY; CELL LINE; COLITIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA; GENE EXPRESSION REGULATION; HUMANS; IMMUNOBLOTTING; IN SITU HYBRIDIZATION; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; SERUM AMYLOID A PROTEIN;

EID: 78149236073     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-10-133     Document Type: Article

References (45)

1. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999, 265(2):501-23. 10.1046/j.1432-1327.1999.00657.x, 10504381.
2. Meek RL, Eriksen N, Benditt EP. Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages. Proc Natl Acad Sci USA 1992, 89(17):7949-52. 10.1073/pnas.89.17.7949, 49832, 1518819.
3. de Beer MC, Yuan T, Kindy MS, Asztalos BF, Roheim PS, de Beer FC. Characterization of constitutive human serum amyloid A protein (SAA4) as an apolipoprotein. J Lipid Res 1995, 36(3):526-34.
4. Eriksen N, Benditt EP. Isolation and characterization of the amyloid-related apoprotein (SAA) from human high density lipoprotein. Proc Natl Acad Sci USA 1980, 77(11):6860-4. 10.1073/pnas.77.11.6860, 350390, 6161374.
5. Coetzee GA, Strachan AF, van der Westhuyzen DR, Hoppe HC, Jeenah MS, de Beer FC. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem 1986, 261(21):9644-51.
6. Tam SP, Kisilevsky R, Ancsin JB. Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages. LoS ONE 2008, 3(12):e3867.
7. Stonik JA, Remaley AT, Demosky SJ, Neufeld EB, Bocharov A, Brewer HB. Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells. Biochem Biophys Res Commun 2004, 321(4):936-41. 10.1016/j.bbrc.2004.07.052, 15358117.
8. van der Westhuyzen DR, Cai L, de Beer MC, de Beer FC. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J Biol Chem 2005, 280(43):35890-5. 10.1074/jbc.M505685200, 16120612.
9. Jahangiri A, de Beer MC, Noffsinger V, Tannock LR, Ramaiah C, Webb NR, van der Westhuyzen DR, de Beer FC. HDL remodeling during the acute phase response. Arterioscler Thromb Vasc Biol 2009, 29(2):261-7. 10.1161/ATVBAHA.108.178681, 2760005, 19008529.
10. van der Westhuyzen DR, de Beer FC, Webb NR. HDL cholesterol transport during inflammation. Curr Opin Lipidol 2007, 18(2):147-151. 10.1097/MOL.0b013e328051b4fe, 17353662.
11. Libby P, Ridker PM, Maseri A. Inflammation and Atherosclerosis. Circulation 2002, 105(9):1135-1143. 10.1161/hc0902.104353, 11877368.
12. He R, Sang H, Ye RD. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 2003, 101(4):1572-81. 10.1182/blood-2002-05-1431, 12393391.
13. Cheng N, He R, Tian J, Ye PP, Ye RD. Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 2008, 181(1):22-6. 2464454, 18566366.
14. Sandri S, Rodriguez D, Gomes E, Monteiro HP, Russo M, Campa A. Is serum amyloid A an endogenous TLR4 agonist?. J Leukoc Biol 2008, 83(5):1174-80. 10.1189/jlb.0407203, 18252871.
15. Shah C, Hari-Dass R, Raynes JG. Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 2006, 108(5):1751-1757. 10.1182/blood-2005-11-011932, 16735604.
16. Marhaug G, Hackett B, Dowton SB. Serum amyloid A gene expression in rabbit, mink and mouse. Clin Exp Immunol 1997, 107(2):425-34. 10.1111/j.1365-2249.1997.287-c31178.x, 9030885.
17. Gutfeld O, Prus D, Ackerman Z, Dishon S, Linke RP, Levin M, Urieli-Shoval S. Expression of Serum Amyloid A, in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa: Implication for a Role in Colonic Tumorigenesis. J Histochem Cytochem 2006, 54(1):63-73. 10.1369/jhc.5A6645.2005, 16116035.
18. Berg RD. The indigenous gastrointestinal microflora. Trends Microbiol 1996, 4(11):430-435. 10.1016/0966-842X(96)10057-3, 8950812.
19. Lievin-Le Moal V, Servin AL. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. 2006, 19(2):315-37. 1471992, 16614252.
20. Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol 2008, 1(1):11-22. 10.1038/mi.2007.6, 19079156.
21. Ouellette AJ. Paneth cells and innate immunity in the crypt microenvironment. Gastroenterology 1997, 113(5):1779-84. 10.1053/gast.1997.v113.pm9352884, 9352884.
22. Wehkamp J, Koslowski M, Wang G, Stange EF. Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease. Mucosal Immunol 2008, 1(Suppl 1):S67-74. 10.1038/mi.2008.48, 19079235.
23. Muller CA, Autenrieth IB, Peschel A. Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci 2005, 62(12):1297-307. 10.1007/s00018-005-5034-2, 15971105.
24. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313(5790):1126-30. 10.1126/science.1127119, 2716667, 16931762.
25. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, Ogunbiyi O, Nunez G, Keshav S. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 2003, 125(1):47-57. 10.1016/S0016-5085(03)00661-9, 12851870.
26. Strober W, Kitani A, Fuss I, Asano N, Watanabe T. The molecular basis of NOD2 susceptibility mutations in Crohn's disease. Mucosal Immunol 2008, 1(Suppl 1):S5-9. 10.1038/mi.2008.42, 19079230.
27. de Villiers WJ, Varilek GW, de Beer FC, Guo JT, Kindy MS. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice. Cytokine 2000, 12(9):1337-47. 10.1006/cyto.2000.0716, 10975993.
28. Zhong J, Eckhardt ER, Oz HS, Bruemmer D, de Villiers WJ. Osteopontin deficiency protects mice from Dextran sodium sulfate-induced colitis. Inflamm Bowel Dis 2006, 12(8):790-796. 10.1097/00054725-200608000-00015, 16917234.
29. Webb NR, de Beer MC, van der Westhuyzen DR, Kindy MS, Banka CL, Tsukamoto K, Rader DL, de Beer FC. Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I- deficient mice. J Lipid Res 1997, 38(8):1583-90.
30. Sousa S, Lecuit M, Cossart P. Microbial strategies to target, cross or disrupt epithelia. Curr Opin Cell Biol 2005, 17(5):489-98. 10.1016/j.ceb.2005.08.013, 16102958.
31. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007, 117(3):514-521. 10.1172/JCI30587, 1804356, 17332878.
32. Fukushima K, Ogawa H, Kitayama T, Yamada T, Naito H, Funayama Y, Matsuno S, Sasaki I. Epithelial induction of serum amyloid A in experimental mucosal inflammation. Dig Dis Sci 2002, 47(7):1438-1446. 10.1023/A:1015834211745, 12141798.
33. Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol 2000, 7(1):64-9. 10.1097/00062752-200001000-00012, 10608507.
34. Reigstad CS, Lunden GO, Felin J, Backhed F. Regulation of serum amyloid A3 (SAA3) in mouse colonic epithelium and adipose tissue by the intestinal microbiota. PLoS ONE 2009, 4(6):e5842. 10.1371/journal.pone.0005842, 2688757, 19513118.
35. Wang H, Liao WS. Functional analysis of a minimal mouse serum amyloid A3 promoter in transgenic mice. Amyloid 2001, 8(4):250-256.
36. Jijon HB, Madsen KL, Walker JW, Allard B, Jobin C. Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells. Eur J Immunol 2005, 35(3):718-726. 10.1002/eji.200425688, 15724247.
37. Kawahara T, Kuwano Y, Teshima-Kondo S, Takeya R, Sumimoto H, Kishi K, Tsunawaki S, Hirayama T, Rokutan K. Role of nicotinamide adenine dinucleotide phosphate oxidase 1 in oxidative burst response to Toll-like receptor 5 signaling in large intestinal epithelial cells. J Immunol 2004, 172(5):3051-3058.
38. Neal MD, Leaphart C, Levy R, Prince J, Billiar TR, Watkins S, Li J, Cetin S, Ford H, Schreiber A. Enterocyte TLR4 Mediates Phagocytosis and Translocation of Bacteria Across the Intestinal Barrier. J Immunol 2006, 176(5):3070-3079.
39. Cai L, Eckhardt ER, Shi W, Zhao Z, Nasser M, De Villiers WJ, Van Der Westhuyzen DR. Scavenger receptor class B type I reduces cholesterol absorption in cultured enterocyte CaCo-2 cells. J Lipid Res 2003, 45(2):253-262. 10.1194/jlr.M300303-JLR200, 14617739.
40. Lobo MV, Huerta L, Ruiz-Velasco N, Teixeiro E, de la Cueva P, Celdran A, Martin-Hidalgo A, Vega MA, Bragado R. Localization of the lipid receptors CD36 and CLA-1/SR-BI in the human gastrointestinal tract: towards the identification of receptors mediating the intestinal absorption of dietary lipids. J Histochem Cytochem 2001, 49(10):1253-60.
41. Cai SF, Kirby RJ, Howles PN, Hui DY. Differentiation-dependent expression and localization of the class B type I scavenger receptor in intestine. J Lipid Res 2001, 42(6SR-BI - expression intestinal cholesterol absorption):902-909.
42. Levy E, Menard D, Suc I, Delvin E, Marcil V, Brissette L, Thibault L, Bendayan M. Ontogeny, immunolocalisation, distribution and function of SR-BI in the human intestine. J Cell Sci 2004, 117(Pt 2):327-337. 10.1242/jcs.00856, 14676281.
43. Bietrix F, Daoguang Y, Nauze M, Rolland C, Bertrand-Michel J, Comera C, Shaak S, Barbaras R, Groen AK, Perret B, Terce F, Collet X. Accelerated lipid absorption in mice overexpressing intestinal SR-BI. J Biol Chem 2006, 281(11):7214-7219. 10.1074/jbc.M508868200, 2034750, 16421100.
44. Philips JA, Rubin EJ, Perrimon N. Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 2005, 309(5738):1251-1253. 10.1126/science.1116006, 16020694.
45. Cai L, de Beer MC, de Beer FC, van der Westhuyzen DR. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J Biol Chem 2005, 280(4):2954-2961. 10.1074/jbc.M411555200, 15561721.